Vespa backs mobile health screening provider with £17m investment
Equity firm Vespa Capital has invested £17m into Bluecrest Health Screening as part of its plan to become a leading health screening provider.
Launched in 2012, Bluecrest is used by over 350 employers to carry out health screenings for their workforce at their premises.
Offering comprehensive health screening tests through a nationwide network of mobile clinics in the UK and Ireland, Bluecrest anticipates that the investment will support its ongoing growth strategy.
Peter Blencowe, managing director at Bluecrest Health Screening, commented: “The support from private equity from Vespa Capital is an endorsement of our vision to become the UK’s leading health screening provider.
“Led by our strengthened board of directors, we’re looking forward to working together to deliver an ambitious five year growth plan, which will see digital services leveraged and a consolidation of our corporate proposition.”
As well as boosting growth, the investment provides an exit for a number of individual seed investors, including Jim Lewcock of BLUE14.io Angel fund.
Jim added: “Bluecrest, with its proactive approach to healthcare, is ideally positioned to succeed in the changing landscape of the UK healthcare system.”
“This investment, combined with new talent being brought into the team, will allow the business to harness the latest technologies and extend its market positioning.”
Access free online guidance for North East businesses in the Growth Hub North East's COVID-19 toolkit →